Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Ronconi

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
International Journal of Cardiology|September 29, 2022
How many and who are patients with heart failure eligible to SGLT2 inhibitors? Responses from the combination of administrative healthcare and primary care databasesCarlo Piccinni, Letizia Dondi, Silvia Calabria, et al.
Recenti Progressi in Medicina|July 1, 2023
[The population affected by neovascular age-related macular degeneration and treated with anti-Vegf through Italian administrative healthcare data.]Silvia Calabria, Giulia Ronconi, Letizia Dondi, et al.
Italian Journal of Dermatology and Venereology|July 29, 2024
Italian healthcare resource consumptions and direct costs of adults with atopic dermatitis before and after dupilumab treatmentGiulia Ronconi, Letizia Dondi, Silvia Calabria, et al.
Endocrine Connections|March 16, 2026
Hypoparathyroidism: clinical profiles, healthcare use and costs from real-world data from ItalyAndrea Palermo, Guido Zavatta, Erica Solaroli, et al.
Expert Review of Clinical Pharmacology|May 25, 2021
Insights into real-world treatment of cluster headache through a large Italian database: prevalence, prescription patterns, and costsCarlo Piccinni, Sabina Cevoli, Giulia Ronconi, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|January 8, 2025
A retrospective observational analysis of the real-world care pathway of people with hereditary transthyretin amyloidosis with polyneuropathy in ItalySilvia Calabria, Giulia Ronconi, Letizia Dondi, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|June 29, 2024
Chronic Kidney Disease Eligible for SGLT2 Inhibitors Through the Integration of Italian Administrative and Primary Care DataCarlo Piccinni, Letizia Dondi, Silvia Calabria, et al.
Recenti Progressi in Medicina|June 15, 2021
[Mutational oncology of lung cancer: molecular markers, drugs, negotiation conditions and experiences in national reference centers.]Immacolata Esposito, Silvia Calabria, Carlo Piccinni, et al.
BMC Pulmonary Medicine|October 22, 2024
Clinical characteristics, use and switch of drugs for obstructive airway diseases among patients with COPD experiencing an exacerbation: a retrospective analysis of Italian administrative healthcare dataLetizia Dondi, Giulia Ronconi, Silvia Calabria, et al.
Clinical Drug Investigation|December 5, 2019
PCSK9 Inhibitors' New Users: Analysis of Prescription Patterns and Patients' Characteristics from an Italian Real-world StudyCarlo Piccinni, Ippazio Cosimo Antonazzo, Aldo P Maggioni, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
International Journal of Cardiology|September 29, 2022
How many and who are patients with heart failure eligible to SGLT2 inhibitors? Responses from the combination of administrative healthcare and primary care databasesCarlo Piccinni, Letizia Dondi, Silvia Calabria, et al.
Recenti Progressi in Medicina|July 1, 2023
[The population affected by neovascular age-related macular degeneration and treated with anti-Vegf through Italian administrative healthcare data.]Silvia Calabria, Giulia Ronconi, Letizia Dondi, et al.
Italian Journal of Dermatology and Venereology|July 29, 2024
Italian healthcare resource consumptions and direct costs of adults with atopic dermatitis before and after dupilumab treatmentGiulia Ronconi, Letizia Dondi, Silvia Calabria, et al.
Endocrine Connections|March 16, 2026
Hypoparathyroidism: clinical profiles, healthcare use and costs from real-world data from ItalyAndrea Palermo, Guido Zavatta, Erica Solaroli, et al.
Expert Review of Clinical Pharmacology|May 25, 2021
Insights into real-world treatment of cluster headache through a large Italian database: prevalence, prescription patterns, and costsCarlo Piccinni, Sabina Cevoli, Giulia Ronconi, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|January 8, 2025
A retrospective observational analysis of the real-world care pathway of people with hereditary transthyretin amyloidosis with polyneuropathy in ItalySilvia Calabria, Giulia Ronconi, Letizia Dondi, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|June 29, 2024
Chronic Kidney Disease Eligible for SGLT2 Inhibitors Through the Integration of Italian Administrative and Primary Care DataCarlo Piccinni, Letizia Dondi, Silvia Calabria, et al.
Recenti Progressi in Medicina|June 15, 2021
[Mutational oncology of lung cancer: molecular markers, drugs, negotiation conditions and experiences in national reference centers.]Immacolata Esposito, Silvia Calabria, Carlo Piccinni, et al.
BMC Pulmonary Medicine|October 22, 2024
Clinical characteristics, use and switch of drugs for obstructive airway diseases among patients with COPD experiencing an exacerbation: a retrospective analysis of Italian administrative healthcare dataLetizia Dondi, Giulia Ronconi, Silvia Calabria, et al.
Clinical Drug Investigation|December 5, 2019
PCSK9 Inhibitors' New Users: Analysis of Prescription Patterns and Patients' Characteristics from an Italian Real-world StudyCarlo Piccinni, Ippazio Cosimo Antonazzo, Aldo P Maggioni, et al.
Pageof 5